ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD4
|
ENSG00000141646.9 | SMAD4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD4 | hg19_v2_chr18_+_48494361_48494426 | 0.49 | 5.2e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_117070037 | 6.47 |
ENST00000392951.4 ENST00000525531.1 ENST00000278968.6 |
TAGLN |
transgelin |
chr1_-_153599732 | 3.89 |
ENST00000392623.1 |
S100A13 |
S100 calcium binding protein A13 |
chr10_+_75670862 | 3.65 |
ENST00000446342.1 ENST00000372764.3 ENST00000372762.4 |
PLAU |
plasminogen activator, urokinase |
chr1_-_153538292 | 3.42 |
ENST00000497140.1 ENST00000368708.3 |
S100A2 |
S100 calcium binding protein A2 |
chr7_+_94023873 | 3.35 |
ENST00000297268.6 |
COL1A2 |
collagen, type I, alpha 2 |
chr11_+_86511569 | 3.13 |
ENST00000441050.1 |
PRSS23 |
protease, serine, 23 |
chr12_+_75874984 | 2.96 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr1_-_153522562 | 2.92 |
ENST00000368714.1 |
S100A4 |
S100 calcium binding protein A4 |
chr12_+_75874460 | 2.74 |
ENST00000266659.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr3_+_159557637 | 2.72 |
ENST00000445224.2 |
SCHIP1 |
schwannomin interacting protein 1 |
chr2_-_56150910 | 2.71 |
ENST00000424836.2 ENST00000438672.1 ENST00000440439.1 ENST00000429909.1 ENST00000424207.1 ENST00000452337.1 ENST00000355426.3 ENST00000439193.1 ENST00000421664.1 |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
chrX_+_102631844 | 2.70 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chrX_+_102631248 | 2.58 |
ENST00000361298.4 ENST00000372645.3 ENST00000372635.1 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr12_+_75874580 | 2.56 |
ENST00000456650.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr3_+_154797877 | 2.56 |
ENST00000462745.1 ENST00000493237.1 |
MME |
membrane metallo-endopeptidase |
chr17_-_7297519 | 2.55 |
ENST00000576362.1 ENST00000571078.1 |
TMEM256-PLSCR3 |
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr7_+_134551583 | 2.41 |
ENST00000435928.1 |
CALD1 |
caldesmon 1 |
chr11_-_111794446 | 2.31 |
ENST00000527950.1 |
CRYAB |
crystallin, alpha B |
chr1_-_153538011 | 2.25 |
ENST00000368707.4 |
S100A2 |
S100 calcium binding protein A2 |
chr1_-_156647189 | 2.24 |
ENST00000368223.3 |
NES |
nestin |
chr3_-_16555150 | 2.23 |
ENST00000334133.4 |
RFTN1 |
raftlin, lipid raft linker 1 |
chr4_+_169418195 | 2.17 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr12_-_8815299 | 2.12 |
ENST00000535336.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr2_+_30454390 | 2.11 |
ENST00000395323.3 ENST00000406087.1 ENST00000404397.1 |
LBH |
limb bud and heart development |
chr2_-_175711133 | 2.11 |
ENST00000409597.1 ENST00000413882.1 |
CHN1 |
chimerin 1 |
chr8_+_22436248 | 2.07 |
ENST00000308354.7 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr9_-_130635741 | 2.07 |
ENST00000223836.10 |
AK1 |
adenylate kinase 1 |
chr12_-_8815215 | 1.99 |
ENST00000544889.1 ENST00000543369.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr7_-_107642348 | 1.97 |
ENST00000393561.1 |
LAMB1 |
laminin, beta 1 |
chr15_+_81071684 | 1.93 |
ENST00000220244.3 ENST00000394685.3 ENST00000356249.5 |
KIAA1199 |
KIAA1199 |
chr21_+_30502806 | 1.88 |
ENST00000399928.1 ENST00000399926.1 |
MAP3K7CL |
MAP3K7 C-terminal like |
chr11_+_35211511 | 1.87 |
ENST00000524922.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr2_-_227664474 | 1.86 |
ENST00000305123.5 |
IRS1 |
insulin receptor substrate 1 |
chr13_+_102104980 | 1.84 |
ENST00000545560.2 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
chr8_+_22436635 | 1.83 |
ENST00000452226.1 ENST00000397760.4 ENST00000339162.7 ENST00000397761.2 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr8_+_1772132 | 1.82 |
ENST00000349830.3 ENST00000520359.1 ENST00000518288.1 ENST00000398560.1 |
ARHGEF10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
chr1_+_26605618 | 1.79 |
ENST00000270792.5 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
chr11_+_35211429 | 1.79 |
ENST00000525688.1 ENST00000278385.6 ENST00000533222.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr16_+_31483374 | 1.78 |
ENST00000394863.3 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
chr3_-_123512688 | 1.76 |
ENST00000475616.1 |
MYLK |
myosin light chain kinase |
chr5_+_125758865 | 1.75 |
ENST00000542322.1 ENST00000544396.1 |
GRAMD3 |
GRAM domain containing 3 |
chr5_-_121413974 | 1.75 |
ENST00000231004.4 |
LOX |
lysyl oxidase |
chr8_-_119964434 | 1.75 |
ENST00000297350.4 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
chr5_+_125758813 | 1.75 |
ENST00000285689.3 ENST00000515200.1 |
GRAMD3 |
GRAM domain containing 3 |
chr6_-_169654139 | 1.75 |
ENST00000366787.3 |
THBS2 |
thrombospondin 2 |
chr3_-_38691119 | 1.74 |
ENST00000333535.4 ENST00000413689.1 ENST00000443581.1 ENST00000425664.1 ENST00000451551.2 |
SCN5A |
sodium channel, voltage-gated, type V, alpha subunit |
chr13_+_102104952 | 1.72 |
ENST00000376180.3 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
chr1_-_201398985 | 1.70 |
ENST00000336092.4 |
TNNI1 |
troponin I type 1 (skeletal, slow) |
chr11_-_61647935 | 1.69 |
ENST00000531956.1 |
FADS3 |
fatty acid desaturase 3 |
chr2_-_190927447 | 1.68 |
ENST00000260950.4 |
MSTN |
myostatin |
chr19_-_36643329 | 1.67 |
ENST00000589154.1 |
COX7A1 |
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
chr1_-_153599426 | 1.66 |
ENST00000392622.1 |
S100A13 |
S100 calcium binding protein A13 |
chrX_-_48931648 | 1.62 |
ENST00000376386.3 ENST00000376390.4 |
PRAF2 |
PRA1 domain family, member 2 |
chr3_-_145878954 | 1.61 |
ENST00000282903.5 ENST00000360060.3 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
chr5_-_111092930 | 1.59 |
ENST00000257435.7 |
NREP |
neuronal regeneration related protein |
chr14_-_105444694 | 1.57 |
ENST00000333244.5 |
AHNAK2 |
AHNAK nucleoprotein 2 |
chr1_+_223889285 | 1.55 |
ENST00000433674.2 |
CAPN2 |
calpain 2, (m/II) large subunit |
chr4_+_169418255 | 1.54 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr5_+_148521381 | 1.53 |
ENST00000504238.1 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr15_+_67420441 | 1.52 |
ENST00000558894.1 |
SMAD3 |
SMAD family member 3 |
chr4_+_41258786 | 1.52 |
ENST00000503431.1 ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
chr11_-_111781610 | 1.51 |
ENST00000525823.1 |
CRYAB |
crystallin, alpha B |
chr19_-_50143452 | 1.50 |
ENST00000246792.3 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
chr5_+_148521046 | 1.49 |
ENST00000326685.7 ENST00000356541.3 ENST00000309868.7 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr13_-_40177261 | 1.49 |
ENST00000379589.3 |
LHFP |
lipoma HMGIC fusion partner |
chr5_+_148521136 | 1.49 |
ENST00000506113.1 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr2_+_170366203 | 1.48 |
ENST00000284669.1 |
KLHL41 |
kelch-like family member 41 |
chr11_-_111781454 | 1.46 |
ENST00000533280.1 |
CRYAB |
crystallin, alpha B |
chr19_-_42463418 | 1.43 |
ENST00000600292.1 ENST00000601078.1 ENST00000601891.1 ENST00000222008.6 |
RABAC1 |
Rab acceptor 1 (prenylated) |
chrX_+_135279179 | 1.42 |
ENST00000370676.3 |
FHL1 |
four and a half LIM domains 1 |
chr15_+_32933866 | 1.42 |
ENST00000300175.4 ENST00000413748.2 ENST00000494364.1 ENST00000497208.1 |
SCG5 |
secretogranin V (7B2 protein) |
chr1_-_201390846 | 1.41 |
ENST00000367312.1 ENST00000555340.2 ENST00000361379.4 |
TNNI1 |
troponin I type 1 (skeletal, slow) |
chr11_-_117186946 | 1.40 |
ENST00000313005.6 ENST00000528053.1 |
BACE1 |
beta-site APP-cleaving enzyme 1 |
chr3_-_114477962 | 1.40 |
ENST00000471418.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr10_-_90712520 | 1.39 |
ENST00000224784.6 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
chr1_+_180165672 | 1.35 |
ENST00000443059.1 |
QSOX1 |
quiescin Q6 sulfhydryl oxidase 1 |
chr17_-_7297833 | 1.35 |
ENST00000571802.1 ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3 |
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr12_-_91572278 | 1.34 |
ENST00000425043.1 ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN |
decorin |
chr6_-_138428613 | 1.34 |
ENST00000421351.3 |
PERP |
PERP, TP53 apoptosis effector |
chr16_+_3070356 | 1.33 |
ENST00000341627.5 ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
chr3_-_99833333 | 1.31 |
ENST00000354552.3 ENST00000331335.5 ENST00000398326.2 |
FILIP1L |
filamin A interacting protein 1-like |
chr12_-_54813229 | 1.30 |
ENST00000293379.4 |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chrX_-_140271249 | 1.29 |
ENST00000370526.2 |
LDOC1 |
leucine zipper, down-regulated in cancer 1 |
chr15_-_83953466 | 1.27 |
ENST00000345382.2 |
BNC1 |
basonuclin 1 |
chr11_-_111781554 | 1.27 |
ENST00000526167.1 ENST00000528961.1 |
CRYAB |
crystallin, alpha B |
chr5_-_111093406 | 1.27 |
ENST00000379671.3 |
NREP |
neuronal regeneration related protein |
chr11_-_27722021 | 1.26 |
ENST00000356660.4 ENST00000418212.1 ENST00000533246.1 |
BDNF |
brain-derived neurotrophic factor |
chr9_+_112810878 | 1.24 |
ENST00000434623.2 ENST00000374525.1 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
chr5_+_34757309 | 1.24 |
ENST00000397449.1 |
RAI14 |
retinoic acid induced 14 |
chr18_+_8717369 | 1.24 |
ENST00000359865.3 ENST00000400050.3 ENST00000306285.7 |
SOGA2 |
SOGA family member 2 |
chr5_-_111093340 | 1.16 |
ENST00000508870.1 |
NREP |
neuronal regeneration related protein |
chr2_-_169104651 | 1.16 |
ENST00000355999.4 |
STK39 |
serine threonine kinase 39 |
chr6_+_146864829 | 1.14 |
ENST00000367495.3 |
RAB32 |
RAB32, member RAS oncogene family |
chr1_-_153600656 | 1.12 |
ENST00000339556.4 ENST00000440685.2 |
S100A13 |
S100 calcium binding protein A13 |
chr20_-_57582296 | 1.10 |
ENST00000217131.5 |
CTSZ |
cathepsin Z |
chr14_+_65007177 | 1.10 |
ENST00000247207.6 |
HSPA2 |
heat shock 70kDa protein 2 |
chr17_-_7307358 | 1.10 |
ENST00000576017.1 ENST00000302422.3 ENST00000535512.1 |
TMEM256 TMEM256-PLSCR3 |
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr12_+_1738363 | 1.08 |
ENST00000397196.2 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
chr11_-_67120974 | 1.08 |
ENST00000539074.1 ENST00000312419.3 |
POLD4 |
polymerase (DNA-directed), delta 4, accessory subunit |
chr3_+_35681081 | 1.07 |
ENST00000428373.1 |
ARPP21 |
cAMP-regulated phosphoprotein, 21kDa |
chr9_+_124088860 | 1.07 |
ENST00000373806.1 |
GSN |
gelsolin |
chr9_+_124030338 | 1.07 |
ENST00000449773.1 ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN |
gelsolin |
chr9_-_14180778 | 1.05 |
ENST00000380924.1 ENST00000543693.1 |
NFIB |
nuclear factor I/B |
chr9_-_130637244 | 1.05 |
ENST00000373156.1 |
AK1 |
adenylate kinase 1 |
chr9_+_112542591 | 1.05 |
ENST00000483909.1 ENST00000314527.4 ENST00000413420.1 ENST00000302798.7 ENST00000555236.1 ENST00000510514.5 |
PALM2 PALM2-AKAP2 AKAP2 |
paralemmin 2 PALM2-AKAP2 readthrough A kinase (PRKA) anchor protein 2 |
chr17_-_76870126 | 1.05 |
ENST00000586057.1 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr9_-_75567962 | 1.04 |
ENST00000297785.3 ENST00000376939.1 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
chr1_+_100111479 | 1.03 |
ENST00000263174.4 |
PALMD |
palmdelphin |
chr2_+_217524323 | 1.02 |
ENST00000456764.1 |
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
chrX_+_54835493 | 1.01 |
ENST00000396224.1 |
MAGED2 |
melanoma antigen family D, 2 |
chr1_+_39796810 | 0.99 |
ENST00000289893.4 |
MACF1 |
microtubule-actin crosslinking factor 1 |
chr9_+_112542572 | 0.99 |
ENST00000374530.3 |
PALM2-AKAP2 |
PALM2-AKAP2 readthrough |
chr19_-_44031375 | 0.98 |
ENST00000292147.2 |
ETHE1 |
ethylmalonic encephalopathy 1 |
chr19_-_43702231 | 0.98 |
ENST00000597374.1 ENST00000599371.1 |
PSG4 |
pregnancy specific beta-1-glycoprotein 4 |
chr19_-_44031341 | 0.97 |
ENST00000600651.1 |
ETHE1 |
ethylmalonic encephalopathy 1 |
chr1_+_203595903 | 0.95 |
ENST00000367218.3 ENST00000367219.3 ENST00000391954.2 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
chr5_-_111093081 | 0.94 |
ENST00000453526.2 ENST00000509427.1 |
NREP |
neuronal regeneration related protein |
chr5_+_82767583 | 0.94 |
ENST00000512590.2 ENST00000513960.1 ENST00000513984.1 ENST00000502527.2 |
VCAN |
versican |
chr17_-_76899275 | 0.93 |
ENST00000322630.2 ENST00000586713.1 |
DDC8 |
Protein DDC8 homolog |
chr6_+_39760129 | 0.92 |
ENST00000274867.4 |
DAAM2 |
dishevelled associated activator of morphogenesis 2 |
chr9_+_139871948 | 0.91 |
ENST00000224167.2 ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS |
prostaglandin D2 synthase 21kDa (brain) |
chr5_-_150521192 | 0.91 |
ENST00000523714.1 ENST00000521749.1 |
ANXA6 |
annexin A6 |
chr10_-_30024716 | 0.90 |
ENST00000375398.2 ENST00000375400.3 |
SVIL |
supervillin |
chr6_-_56707943 | 0.90 |
ENST00000370769.4 ENST00000421834.2 ENST00000312431.6 ENST00000361203.3 ENST00000523817.1 |
DST |
dystonin |
chr2_+_33359646 | 0.90 |
ENST00000390003.4 ENST00000418533.2 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr1_-_201391149 | 0.90 |
ENST00000555948.1 ENST00000556362.1 |
TNNI1 |
troponin I type 1 (skeletal, slow) |
chr8_-_145028013 | 0.90 |
ENST00000354958.2 |
PLEC |
plectin |
chr1_+_100111580 | 0.89 |
ENST00000605497.1 |
PALMD |
palmdelphin |
chr2_+_33359687 | 0.88 |
ENST00000402934.1 ENST00000404525.1 ENST00000407925.1 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr2_+_69240415 | 0.88 |
ENST00000409829.3 |
ANTXR1 |
anthrax toxin receptor 1 |
chr1_+_203595689 | 0.88 |
ENST00000357681.5 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
chr16_-_28550348 | 0.87 |
ENST00000324873.6 |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
chr18_+_12308231 | 0.87 |
ENST00000590103.1 ENST00000591909.1 ENST00000586653.1 ENST00000592683.1 ENST00000590967.1 ENST00000591208.1 ENST00000591463.1 |
TUBB6 |
tubulin, beta 6 class V |
chr4_-_111563076 | 0.87 |
ENST00000354925.2 ENST00000511990.1 |
PITX2 |
paired-like homeodomain 2 |
chr2_+_69240511 | 0.85 |
ENST00000409349.3 |
ANTXR1 |
anthrax toxin receptor 1 |
chr2_+_69240302 | 0.85 |
ENST00000303714.4 |
ANTXR1 |
anthrax toxin receptor 1 |
chr1_-_110283138 | 0.84 |
ENST00000256594.3 |
GSTM3 |
glutathione S-transferase mu 3 (brain) |
chr7_-_27219849 | 0.83 |
ENST00000396344.4 |
HOXA10 |
homeobox A10 |
chr11_-_72385437 | 0.83 |
ENST00000418754.2 ENST00000542969.2 ENST00000334456.5 |
PDE2A |
phosphodiesterase 2A, cGMP-stimulated |
chr19_-_36523709 | 0.82 |
ENST00000592017.1 ENST00000360535.4 |
CLIP3 |
CAP-GLY domain containing linker protein 3 |
chr8_-_48651648 | 0.82 |
ENST00000408965.3 |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
chr17_+_41476327 | 0.81 |
ENST00000320033.4 |
ARL4D |
ADP-ribosylation factor-like 4D |
chr22_+_31488433 | 0.81 |
ENST00000455608.1 |
SMTN |
smoothelin |
chr12_+_96588143 | 0.81 |
ENST00000228741.3 ENST00000547249.1 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr4_-_102268484 | 0.79 |
ENST00000394853.4 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr16_-_10652993 | 0.79 |
ENST00000536829.1 |
EMP2 |
epithelial membrane protein 2 |
chr17_-_78009647 | 0.77 |
ENST00000310924.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chr4_+_671711 | 0.77 |
ENST00000400159.2 |
MYL5 |
myosin, light chain 5, regulatory |
chr5_+_140864649 | 0.77 |
ENST00000306593.1 |
PCDHGC4 |
protocadherin gamma subfamily C, 4 |
chrX_-_17879356 | 0.77 |
ENST00000331511.1 ENST00000415486.3 ENST00000545871.1 ENST00000451717.1 |
RAI2 |
retinoic acid induced 2 |
chr15_+_43803143 | 0.76 |
ENST00000382031.1 |
MAP1A |
microtubule-associated protein 1A |
chr10_+_123872483 | 0.76 |
ENST00000369001.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr1_+_101185290 | 0.75 |
ENST00000370119.4 ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1 |
vascular cell adhesion molecule 1 |
chr3_+_100211412 | 0.75 |
ENST00000323523.4 ENST00000403410.1 ENST00000449609.1 |
TMEM45A |
transmembrane protein 45A |
chr7_-_99764907 | 0.75 |
ENST00000413800.1 |
GAL3ST4 |
galactose-3-O-sulfotransferase 4 |
chr11_+_9685604 | 0.75 |
ENST00000447399.2 ENST00000318950.6 |
SWAP70 |
SWAP switching B-cell complex 70kDa subunit |
chr14_-_23288930 | 0.74 |
ENST00000554517.1 ENST00000285850.7 ENST00000397529.2 ENST00000555702.1 |
SLC7A7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr8_+_22409193 | 0.73 |
ENST00000240123.7 |
SORBS3 |
sorbin and SH3 domain containing 3 |
chrX_-_68385274 | 0.73 |
ENST00000374584.3 ENST00000590146.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr20_+_60174827 | 0.73 |
ENST00000543233.1 |
CDH4 |
cadherin 4, type 1, R-cadherin (retinal) |
chr11_+_71900703 | 0.73 |
ENST00000393681.2 |
FOLR1 |
folate receptor 1 (adult) |
chr9_-_130617029 | 0.72 |
ENST00000373203.4 |
ENG |
endoglin |
chr19_-_45926739 | 0.72 |
ENST00000589381.1 ENST00000591636.1 ENST00000013807.5 ENST00000592023.1 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr11_+_67777751 | 0.72 |
ENST00000316367.6 ENST00000007633.8 ENST00000342456.6 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
chr19_-_43709817 | 0.72 |
ENST00000433626.2 ENST00000405312.3 |
PSG4 |
pregnancy specific beta-1-glycoprotein 4 |
chr6_-_109777128 | 0.71 |
ENST00000358807.3 ENST00000358577.3 |
MICAL1 |
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
chr4_-_102267953 | 0.71 |
ENST00000523694.2 ENST00000507176.1 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr9_+_34652164 | 0.71 |
ENST00000441545.2 ENST00000553620.1 |
IL11RA |
interleukin 11 receptor, alpha |
chr9_+_120466610 | 0.71 |
ENST00000394487.4 |
TLR4 |
toll-like receptor 4 |
chrX_+_49028265 | 0.71 |
ENST00000376322.3 ENST00000376327.5 |
PLP2 |
proteolipid protein 2 (colonic epithelium-enriched) |
chrX_+_54834791 | 0.71 |
ENST00000218439.4 ENST00000375058.1 ENST00000375060.1 |
MAGED2 |
melanoma antigen family D, 2 |
chr18_-_53253112 | 0.71 |
ENST00000568673.1 ENST00000562847.1 ENST00000568147.1 |
TCF4 |
transcription factor 4 |
chrX_-_68385354 | 0.70 |
ENST00000361478.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr9_-_130616915 | 0.68 |
ENST00000344849.3 |
ENG |
endoglin |
chrX_+_152086373 | 0.68 |
ENST00000318529.8 |
ZNF185 |
zinc finger protein 185 (LIM domain) |
chr19_+_38755042 | 0.68 |
ENST00000301244.7 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
chr6_+_12290586 | 0.68 |
ENST00000379375.5 |
EDN1 |
endothelin 1 |
chr20_-_56265680 | 0.67 |
ENST00000414037.1 |
PMEPA1 |
prostate transmembrane protein, androgen induced 1 |
chr9_+_90341024 | 0.65 |
ENST00000340342.6 ENST00000342020.5 |
CTSL |
cathepsin L |
chr10_-_62704005 | 0.65 |
ENST00000337910.5 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr1_-_59249732 | 0.64 |
ENST00000371222.2 |
JUN |
jun proto-oncogene |
chr10_+_31610064 | 0.64 |
ENST00000446923.2 ENST00000559476.1 |
ZEB1 |
zinc finger E-box binding homeobox 1 |
chr7_+_23286182 | 0.64 |
ENST00000258733.4 ENST00000381990.2 ENST00000409458.3 ENST00000539136.1 ENST00000453162.2 |
GPNMB |
glycoprotein (transmembrane) nmb |
chr6_-_112080256 | 0.63 |
ENST00000462856.2 ENST00000229471.4 |
FYN |
FYN oncogene related to SRC, FGR, YES |
chr6_+_44184653 | 0.63 |
ENST00000573382.2 ENST00000576476.1 |
RP1-302G2.5 |
RP1-302G2.5 |
chr2_+_201170596 | 0.62 |
ENST00000439084.1 ENST00000409718.1 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr2_-_208030647 | 0.62 |
ENST00000309446.6 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
chr16_-_66959429 | 0.62 |
ENST00000420652.1 ENST00000299759.6 |
RRAD |
Ras-related associated with diabetes |
chr7_+_114562172 | 0.62 |
ENST00000393486.1 ENST00000257724.3 |
MDFIC |
MyoD family inhibitor domain containing |
chr5_+_148206156 | 0.62 |
ENST00000305988.4 |
ADRB2 |
adrenoceptor beta 2, surface |
chr15_+_68924327 | 0.62 |
ENST00000543950.1 |
CORO2B |
coronin, actin binding protein, 2B |
chr10_-_735553 | 0.62 |
ENST00000280886.6 ENST00000423550.1 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr16_+_1583567 | 0.61 |
ENST00000566264.1 |
TMEM204 |
transmembrane protein 204 |
chr11_-_67276100 | 0.61 |
ENST00000301488.3 |
CDK2AP2 |
cyclin-dependent kinase 2 associated protein 2 |
chr19_+_38755203 | 0.61 |
ENST00000587090.1 ENST00000454580.3 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
chr1_+_198126093 | 0.61 |
ENST00000367385.4 ENST00000442588.1 ENST00000538004.1 |
NEK7 |
NIMA-related kinase 7 |
chr19_-_43709772 | 0.61 |
ENST00000596907.1 ENST00000451895.1 |
PSG4 |
pregnancy specific beta-1-glycoprotein 4 |
chr18_-_53253323 | 0.61 |
ENST00000540999.1 ENST00000563888.2 |
TCF4 |
transcription factor 4 |
chr19_-_46285646 | 0.60 |
ENST00000458663.2 |
DMPK |
dystrophia myotonica-protein kinase |
chr2_+_18059906 | 0.59 |
ENST00000304101.4 |
KCNS3 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 9.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 3.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 6.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 5.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 11.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 5.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 3.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 2.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 4.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 7.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 3.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 4.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 6.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 3.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 4.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 5.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 2.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 7.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 2.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 2.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.5 | 1.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.4 | 2.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.4 | 6.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 1.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 0.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 1.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 4.5 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.2 | GO:0031673 | H zone(GO:0031673) |
0.3 | 3.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 6.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 0.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.2 | 1.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 1.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 4.0 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 6.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 8.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0097679 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
0.1 | 3.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 1.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 3.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 6.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.5 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 2.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 1.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 2.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 13.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 1.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 2.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 1.0 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 1.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 1.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 1.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 1.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.6 | 1.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.5 | 2.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 1.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.5 | 1.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 9.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 1.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.4 | 1.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 1.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 3.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.3 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 1.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.3 | 1.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 1.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.3 | 1.1 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.3 | 1.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.3 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 3.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 0.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 6.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 2.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.4 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 4.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 3.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 1.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.4 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 5.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 1.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.8 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 3.8 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 1.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 2.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 2.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.0 | 5.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 9.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 3.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 2.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 1.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 1.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 1.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.5 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 6.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 2.6 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.7 | 1.4 | GO:0001300 | chronological cell aging(GO:0001300) |
0.6 | 2.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 3.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 1.8 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.5 | 1.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 1.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 1.5 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.5 | 1.9 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.4 | 3.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 1.7 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.4 | 1.3 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
0.4 | 2.1 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.4 | 1.3 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.4 | 1.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) negative regulation of skeletal muscle cell proliferation(GO:0014859) regulation of skeletal muscle tissue growth(GO:0048631) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.4 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.4 | 4.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.4 | 6.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 1.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.3 | 2.4 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.3 | 0.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 2.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.3 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.5 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.3 | 2.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.9 | GO:0060460 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.3 | 4.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) positive regulation of t-circle formation(GO:1904431) |
0.3 | 1.1 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
0.3 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 2.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.3 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 1.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 1.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.7 | GO:0070428 | negative regulation of interleukin-23 production(GO:0032707) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.2 | 1.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 3.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 1.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 2.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.8 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.2 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 1.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.5 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.2 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 3.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.2 | 0.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.2 | 1.1 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 1.5 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.1 | 1.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.1 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.8 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 1.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 1.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.4 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 4.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 0.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.6 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.1 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.3 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.1 | 1.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.2 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 2.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.8 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.2 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.1 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.3 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.1 | 1.2 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.1 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.1 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 3.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 1.8 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 1.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.5 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.4 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 1.3 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) DNA dephosphorylation(GO:0098502) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.0 | 0.9 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) |
0.0 | 0.0 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 1.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.7 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
0.0 | 2.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 1.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 1.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:2000255 | regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.5 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.0 | 0.1 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.0 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.9 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.4 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 1.2 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:1903943 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 | 0.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 1.1 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:1902946 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) protein localization to early endosome(GO:1902946) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 1.4 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.1 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 1.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.6 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.0 | 0.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 1.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.5 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.1 | GO:0032341 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 1.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |